We are delighted to announce that Morningside Pharmaceuticals Ltd has won at the Pharmacy Business Awards, in the category of Innovation in Genetics.
The awards, held at the Intercontinental London, hailed the achievements of community pharmacists across the UK and was attended by 900 guests, including Steve Brine, the Minister with responsibility for Pharmacy at the Department of Health. The event was hosted by Rory Bremner.
The awards gave recognition for the role of the pharmaceutical industry and Morningside were recognised for our innovations in the generics market and in improving patient care.
The judges said: “One of the fastest growing pharma companies in the industry, Morningside makes niche medicines in a number of therapeutic areas.
“Over the last year it has launched 12 new niche products some of which include novel technology towards slow-release formulations, bringing innovation and choice to both pharmacists and patients.”
The award was collected by Dr Nik Kotecha OBE, Chief Executive, of Morningside.
